[go: up one dir, main page]

ES488665A0 - PROCEDURE FOR OBTAINING A NEW ANTI-AGES-CLEROTIC COMPOUND - Google Patents

PROCEDURE FOR OBTAINING A NEW ANTI-AGES-CLEROTIC COMPOUND

Info

Publication number
ES488665A0
ES488665A0 ES488665A ES488665A ES488665A0 ES 488665 A0 ES488665 A0 ES 488665A0 ES 488665 A ES488665 A ES 488665A ES 488665 A ES488665 A ES 488665A ES 488665 A0 ES488665 A0 ES 488665A0
Authority
ES
Spain
Prior art keywords
clerotic
ages
procedure
obtaining
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES488665A
Other languages
Spanish (es)
Other versions
ES8101585A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Original Assignee
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sociedad Espanola de Especialidades Farmaco Terapeuticas SA filed Critical Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority to ES488665A priority Critical patent/ES8101585A1/en
Priority to FR8017235A priority patent/FR2476095A1/en
Priority to BE2/58700A priority patent/BE884722A/en
Publication of ES488665A0 publication Critical patent/ES488665A0/en
Publication of ES8101585A1 publication Critical patent/ES8101585A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES488665A 1980-02-15 1980-02-15 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels Expired ES8101585A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES488665A ES8101585A1 (en) 1980-02-15 1980-02-15 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels
FR8017235A FR2476095A1 (en) 1980-02-15 1980-08-01 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels
BE2/58700A BE884722A (en) 1980-02-15 1980-08-12 NOVEL SYMMETRIC MIXED ESTER OF 1,2,3-TRIHYDROXYPROPANE, PROCESS FOR OBTAINING SAME AND THERAPEUTIC APPLICATIONS THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES488665A ES8101585A1 (en) 1980-02-15 1980-02-15 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels

Publications (2)

Publication Number Publication Date
ES488665A0 true ES488665A0 (en) 1980-12-16
ES8101585A1 ES8101585A1 (en) 1980-12-16

Family

ID=8479833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488665A Expired ES8101585A1 (en) 1980-02-15 1980-02-15 Glyceryl 2-para-chloro:phenoxy-isobutyrate-1,3-di:nicotinate - hypolipaemic and hypocholesterolaemic used to treat atherosclerosis, hyperlipoproteinaemia and high tri:glyceride plasma levels

Country Status (3)

Country Link
BE (1) BE884722A (en)
ES (1) ES8101585A1 (en)
FR (1) FR2476095A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692262B1 (en) * 1992-06-10 1994-08-05 Adir NOVEL DIACYLGLYCEROLS NICOTINATES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
HU230435B1 (en) 2001-01-26 2016-06-28 Merck Sharp & Dohme Corp Use of substituted azetidinone compounds for treatment of sitosterolemia
RS20100015A (en) 2001-01-26 2010-12-31 Schering Corporation Combination of receptor activator activated by fenofibrate peroxisome-proliferator (ppar) with sterol absorption inhibitor ezetimibe for vascular indications
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
CA2460340C (en) 2001-09-21 2011-02-15 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
MXPA05004811A (en) 2002-11-06 2005-07-22 Schering Corp Cholesterol absorptions inhibitors for the treatment of autoimmune disorders.
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
MXPA05009501A (en) 2003-03-07 2005-10-18 Schering Corp Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia.
MXPA05009502A (en) 2003-03-07 2005-10-18 Schering Corp Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia.
AR065670A1 (en) 2007-03-09 2009-06-24 Indigene Pharmaceuticals Inc COMBINATION OF METFORMIN R - (+) LIPOATE AND ANTIHIPERLIPIDEMIC AGENTS FOR THE TREATMENT OF DIABETIC HYPERGLUCEMIA AND DIABETIC COMPLICATIONS
CN107405325B (en) 2015-02-06 2021-11-12 英特塞普特医药品公司 Pharmaceutical compositions for combination therapy
CA3142358A1 (en) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease

Also Published As

Publication number Publication date
BE884722A (en) 1980-12-01
FR2476095B1 (en) 1984-03-09
FR2476095A1 (en) 1981-08-21
ES8101585A1 (en) 1980-12-16

Similar Documents

Publication Publication Date Title
ES523838A0 (en) A NEW CARBOSTIRILE DERIVATIVE.
ES501130A0 (en) PROCEDURE FOR OBTAINING MUCOPOLISACARIDES
ES506714A0 (en) A PROCEDURE FOR OBTAINING BICYCLE COMPOUNDS
DK29881A (en) PROCEDURE FOR MAKING POLYETHER COMPOUNDS
ES488665A0 (en) PROCEDURE FOR OBTAINING A NEW ANTI-AGES-CLEROTIC COMPOUND
ES503134A0 (en) A PROCEDURE FOR PREPARING NEW CEFEM COMPOUNDS
MX159179A (en) IMPROVED PROCESS FOR OBTAINING A POLYNITROAROMATIC COMPOUND
ES505498A0 (en) A PROCEDURE FOR PREPARING NEW CEFEM COMPOUNDS
ES503494A0 (en) A PROCEDURE FOR ENCAPSULATING WASTE
ES502180A0 (en) PROCEDURE FOR OBTAINING A NEW GASTRIC ANTICIATE
ES503491A0 (en) A METAPHENYLENDIAMINE PREPARATION PROCEDURE
RO81354A (en) PROCEDURE FOR OBTAINING ANTIBIOTIC TILACTONE MACROLID
ES500478A0 (en) A PROCEDURE FOR OBTAINING BICYCLOOCTAN DERIVATIVES
ES505886A0 (en) A PROCEDURE FOR OBTAINING NEW BETA-LAC-TAMA COMPOUNDS
ES503805A0 (en) A SYNTHESIS PROCEDURE FOR N (1-ALYL-2-PIRROLIDINYL-METHYL) -2-METOXI-4-AMINO-5-METHYLSULFAMOIL-BENZAMIDE
AR229471A1 (en) PROCEDURE FOR THE PREPARATION OF A DERIVATIVE OF ALCOXI-CARBONILHEXIL-METOXIFENIL PIPERAZINA
ES505714A0 (en) A PROCEDURE FOR PREPARING CEFEM COMPOUNDS
ES497763A0 (en) PROCEDURE FOR OBTAINING NEW 2-AMINOETHANOLS
ES505978A0 (en) PROCEDURE FOR OBTAINING A NEW DIOXOLANIC COMPOUND
ES517622A0 (en) PROCEDURE FOR PREPARING A NEW SPIRODEAN.
ES490248A0 (en) PROCEDURE FOR OBTAINING A NEW POLYFUNCTIONAL DISULFIDE COMPOUND
RO81341A2 (en) PROCEDURE FOR OBTAINING DIACETILMONOXIME
DK411781A (en) METHOD FOR MAKING CEPHALOSPOR COMPOUNDS
ES495309A0 (en) A PROCEDURE FOR PREPARING A BEZAMIDE COMPOUND
ES496877A0 (en) PROCEDURE FOR OBTAINING A BENZOTIAZINE DERIVATIVE

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 19991217